Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by prophetoffactzon May 25, 2023 8:47pm
81 Views
Post# 35464976

RE:Gagnon.

RE:Gagnon.
Alex1726 wrote:
I wonder if we will see Gagnon's jerk face in the coming months on the screen claiming this share price will be history. I think he'll keep a very low profile asking himself how much more can i grab in the ceapro's bank.


With the clinical Phase I avenanthramide clinical trial enrolling within the next 30 days and the 'go / no go' decision for the fibrosis clinical trial this summer CZO's life as a pharma is just beginning. 

This avenanthramide clinical trial had inflammation clinical readouts at 8 weeks:
Effects of Avenanthramide-enriched Oats on Inflammation - Full Text View - ClinicalTrials.gov

Hopefully the base business is back to reordering from J&J in Q3 which is reported in November. 
<< Previous
Bullboard Posts
Next >>